September 11-14, 2022

bioAffinity Technologies Presents its CyPath^® Lung test and Exhibits at the National Association of Veterans’ Research and Education Foundation (NAVREF)

President and Chief Executive Officer Maria Zannes will speak about bioAffinity Technologies and CyPath^® Lung, the Company’s non-invasive test to detect early-stage lung cancer, to senior research and medical professionals dedicated to advancing veterans’ healthcare at the Annual Meeting of the National Association of Veterans’ Research and Education Foundation (NAVREF) September 11-14, 2022 in Washington DC.  bioAffinity Technologies also will exhibit at the annual gathering that brings together physicians, researchers and administrators to discuss and advance VA-affiliated research and education.